These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3860275)

  • 1. Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression.
    Duquette P; Décary F; Pleines J; Boivin D; Lamoureux G; Cosgrove JB; Lapierre Y
    Can J Neurol Sci; 1985 May; 12(2):106-10. PubMed ID: 3860275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes.
    Madigand M; Oger JJ; Fauchet R; Sabouraud O; Genetet B
    J Neurol Sci; 1982 Mar; 53(3):519-29. PubMed ID: 6978384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histocompatibility antigens in familial multiple sclerosis in a high-risk area of the disease.
    Kinnunen E; Koskimies S; Lagerstedt A; Wikström J
    J Neurol Sci; 1984 Aug; 65(2):147-55. PubMed ID: 6592288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland.
    Haegert DG; Swift FV; Benedikz J
    Neurology; 1996 Apr; 46(4):1107-11. PubMed ID: 8780100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complement markers Bf and C4 in multiple sclerosis].
    Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
    Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis.
    Alvarado-de la Barrera C; Zúñiga-Ramos J; Ruíz-Morales JA; Estañol B; Granados J; Llorente L
    Neurology; 2000 Dec; 55(12):1897-900. PubMed ID: 11134391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antigens and progression of multiple sclerosis. Part II.
    Dejaegher L; de Bruyere M; Ketelaer P; Carton H
    J Neurol; 1983; 229(3):167-74. PubMed ID: 6191008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnic and HLA patterns related to multiple sclerosis in Wellington, New Zealand.
    Miller DH; Hornabrook RW; Dagger J; Fong R
    J Neurol Neurosurg Psychiatry; 1986 Jan; 49(1):43-6. PubMed ID: 3457100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
    Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
    Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA and multiple sclerosis: population and families study.
    Govaerts A; Gony J; Martin-Mondiére C; Poirier JC; Schmid M; Schuller E; Degos JD; Dausset J
    Tissue Antigens; 1985 Apr; 25(4):187-99. PubMed ID: 3874450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens-linked genetic control in multiple sclerosis patients resistant and susceptible to infection.
    Lamoureux G; Duquette P; Lapierre Y; Cosgrove B; Bourret G; Labrie L
    J Neurol; 1983; 230(2):91-104. PubMed ID: 6196464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis.
    McDonnell GV; Mawhinney H; Graham CA; Hawkins SA; Middleton D
    J Neurol Sci; 1999 May; 165(1):77-83. PubMed ID: 10426152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between HLA-D region epitopes and multiple sclerosis in Arabs.
    Al-Din AS; Al-Saffar M; Siboo R; Behbehani K
    Tissue Antigens; 1986 Apr; 27(4):196-200. PubMed ID: 2425452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-D typing in multiple sclerosis: Israelis tested with European homozygous typing cells.
    Brautbar C; Amar A; Cohen N; Oksenberg J; Cohen I; Kahana E; Bloch D; Alter M; Grosse-Wilde H
    Tissue Antigens; 1982 Mar; 19(3):189-97. PubMed ID: 6953617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA and heterogeneity of multiple sclerosis.
    Engell T; Raun NE; Thomsen M; Platz P
    Neurology; 1982 Sep; 32(9):1043-6. PubMed ID: 6955632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence.
    Poirier G; Montplaisir J; Décary F; Momège D; Lebrun A
    Sleep; 1986; 9(1 Pt 2):153-8. PubMed ID: 3486443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA antigens in multiple sclerosis in coloured South Africans.
    Fewster ME; Kies B
    J Neurol Sci; 1984; 66(2-3):175-81. PubMed ID: 6597862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews.
    Kwon OJ; Karni A; Israel S; Brautbar C; Amar A; Meiner Z; Abramsky O; Karussis D
    Arch Neurol; 1999 May; 56(5):555-60. PubMed ID: 10328250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The risk factors for the development of multiple sclerosis in the Moscow population. II. The combination of exogenous and hereditary factors].
    Gusev EI; Boĭko AN; Demina TL; Sudomoina MA; Alekseev AP; Boldyreva MN; Trofimov DIu; Favorova OO
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(6):47-52. PubMed ID: 10441868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Class II HLA antigens in patients with multiple sclerosis from Warsaw and Gdansk regions].
    Fryze W; Członkowska A; Bieganowska K; Kłos M; Nowak J; Obiedziński R; Szirkowiec W
    Neurol Neurochir Pol; 1997; 31(2):229-36. PubMed ID: 9380253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.